Robert J. Alpern - 30 Jun 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Robert J. Alpern by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
30 Jun 2023
Transactions value $
$7,849
Form type
4
Filing time
05 Jul 2023, 11:54:21
Previous filing
09 May 2023
Next filing
11 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $7.85K +72 +0.78% $109.02 9.27K 30 Jun 2023 Common Shares 72 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.